Healthcare - Genomics & Precision Medicine
Companies in gene therapy, genetic testing, and personalized medicine platforms
Gene Therapy & Gene Editing60
RNA Therapeutics10
Genetic Testing & Diagnostics23
Precision Medicine Platforms49
 AZN | AstraZeneca PLC | Precision Medicine Platforms | $263.1b | $169.90 | +2.0% | 1.1M |
 TMO | Thermo Fisher Scientific, Inc. | Precision Medicine Platforms | $212.2b | $625.09 | -0.4% | 589.1K |
 DHR | Danaher Corporation | Precision Medicine Platforms | $137.1b | $214.47 | +0.2% | 719.2K |
 VRTX | Vertex Pharmaceuticals Inc | Gene Therapy & Gene Editing | $119.5b | $554.15 | +1.2% | 150.1K |
 REGN | Regeneron Pharmaceuticals Inc | Gene Therapy & Gene Editing | $78.2b | $836.51 | +1.3% | 198.1K |
 NTRA | Natera, Inc. Common Stock | Genetic Testing & Diagnostics | $38.7b | $333.06 | +1.9% | 968.9K |
 WAT | Waters Corp | Precision Medicine Platforms | $36.8b | $411.98 | +0.6% | 137.8K |
 ILMN | Illumina Inc | Genetic Testing & Diagnostics | $31.0b | $224.29 | +0.9% | 394.1K |
 ALNY | Alnylam Pharmaceuticals, Inc. | RNA Therapeutics | $27.5b | $239.08 | +1.1% | 422.7K |
 LH | Labcorp Holdings Inc. | Genetic Testing & Diagnostics | $25.0b | $334.08 | -1.5% | 213.2K |
 GH | Guardant Health, Inc. Common Stock | Precision Medicine Platforms | $21.7b | $166.51 | +2.1% | 391.7K |
 INSM | Insmed, Inc. | Gene Therapy & Gene Editing | $21.4b | $125.50 | +1.6% | 408.0K |
 BBIO | BridgeBio Pharma, Inc. Common Stock | Precision Medicine Platforms | $15.7b | $80.76 | -0.2% | 351.0K |
 RVTY | Revvity, Inc. | Precision Medicine Platforms | $12.9b | $124.19 | +1.3% | 171.8K |
 ARWR | Arrowhead Research Corporation | RNA Therapeutics | $11.9b | $88.81 | +2.6% | 281.2K |
 BMRN | BioMarin Pharmaceuticals Inc | Gene Therapy & Gene Editing | $11.6b | $66.05 | +1.8% | 279.8K |
 TECH | Bio-Techne Corp. | Precision Medicine Platforms | $11.2b | $72.33 | -0.1% | 831.9K |
 KRYS | Krystal Biotech, Inc. Common Stock | Gene Therapy & Gene Editing | $10.1b | $353.77 | +3.6% | 52.5K |
 NUVL | Nuvalent, Inc. Class A Common Stock | Precision Medicine Platforms | $9.8b | $123.96 | 0.0% | N/A |
 QGEN | QIAGEN N.V. | Genetic Testing & Diagnostics | $8.7b | $42.86 | +2.8% | 969.0K |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | RNA Therapeutics | $8.6b | $63.86 | +2.9% | 935.3K |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | Precision Medicine Platforms | $8.5b | $367.26 | +0.1% | 125.1K |
 KYMR | Kymera Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $8.5b | $124.22 | +2.9% | 138.5K |
 TEM | Tempus AI, Inc. Class A Common Stock | Precision Medicine Platforms | $8.3b | $69.72 | +5.3% | 4.6M |
 LNTH | Lantheus Holdings, Inc | Precision Medicine Platforms | $6.5b | $100.99 | +0.2% | 313.0K |
 BLLN | BillionToOne, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $6.4b | $97.78 | +1.0% | 252.2K |
 TWST | Twist Bioscience Corporation Common Stock | Precision Medicine Platforms | $6.3b | $152.43 | +8.7% | 600.3K |
 TXG | 10x Genomics, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $6.0b | $65.85 | +4.0% | 1.2M |
 CRSP | CRISPR Therapeutics AG | Gene Therapy & Gene Editing | $4.7b | $60.99 | +7.4% | 982.1K |
 DYN | Dyne Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $4.7b | $26.20 | +1.0% | 492.5K |
 FOLD | Amicus Therapeutics, Inc | Gene Therapy & Gene Editing | $4.5b | $14.49 | +0.0% | 3.5M |
 CAI | Caris Life Sciences, Inc. Common Stock | Precision Medicine Platforms | $4.4b | $27.24 | +3.5% | 1.7M |
 VCYT | Veracyte, Inc. | Genetic Testing & Diagnostics | $3.6b | $42.96 | +3.7% | 219.3K |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | Precision Medicine Platforms | $3.6b | $26.28 | +2.9% | 363.5K |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | Precision Medicine Platforms | $3.4b | $41.81 | +4.6% | 299.0K |
 QURE | uniQure N.V. | Gene Therapy & Gene Editing | $3.1b | $49.55 | +5.4% | 839.7K |
 BEAM | Beam Therapeutics Inc. Common Stock | Gene Therapy & Gene Editing | $2.6b | $31.18 | +10.1% | 695.0K |
 VCEL | Vericel Corporation | Gene Therapy & Gene Editing | $2.4b | $43.05 | +1.1% | 120.3K |
 PGEN | Precigen, Inc. Common Stock | Gene Therapy & Gene Editing | $2.4b | $7.36 | +2.4% | 1.5M |
 CDNA | CareDx, Inc. | Genetic Testing & DiagnosticsPrecision Medicine Platforms | $2.3b | $49.64 | +4.4% | 673.9K |
 NEO | NeoGenomics, Inc. | Genetic Testing & Diagnostics | $2.0b | $16.75 | +2.0% | 179.2K |
 WGS | GeneDx Holdings Corp. Class A Common Stock | Genetic Testing & DiagnosticsPrecision Medicine Platforms | $2.0b | $87.51 | +2.6% | 211.8K |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | Gene Therapy & Gene Editing | $1.7b | $18.88 | +4.7% | 393.0K |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | Gene Therapy & Gene Editing | $1.7b | $6.21 | +4.4% | 308.4K |
 BLFS | BioLife Solutions Inc. | Gene Therapy & Gene Editing | $1.5b | $37.25 | +0.4% | 153.5K |
 MAZE | Maze Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $1.5b | $30.59 | +3.0% | 116.3K |
 NTLA | Intellia Therapeutics, Inc | Gene Therapy & Gene Editing | $1.5b | $13.59 | +8.6% | 1.6M |
 PSNL | Personalis, Inc. Common Stock | Genetic Testing & Diagnostics | $1.4b | $17.39 | +2.2% | 1.2M |
 AZTA | Azenta, Inc. | Genetic Testing & Diagnostics | $1.3b | $33.77 | +2.2% | 229.6K |
 WVE | Wave Life Sciences Ltd. Ordinary Shares | RNA Therapeutics | $1.1b | $5.29 | +3.6% | 684.9K |